News tagged with american society of clinical oncology
Related topics: cancer , cancer patients , chemotherapy
Lung cancer CT scans: Just for older heavy smokers
New lung cancer screening guidelines from three medical groups recommend annual scans but only for an older group of current or former heavy smokers.
Cancer
May 20, 2012 |
5 / 5 (1) |
0
ASCO: For chemo's nausea, olanzapine beats metoclopramide
(HealthDay) -- For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment ...
Cancer
May 17, 2012 |
not rated yet |
0
ASCO: Dabrafenib/Trametinib active in metastatic melanoma
(HealthDay) -- For patients with V600 BRAF-mutant solid tumors, treatment with the oral BRAF inhibitor dabrafenib and the oral MEK 1/2 inhibitor trametinib is tolerated and has clinical activity in BRAF inh ...
Cancer
May 17, 2012 |
not rated yet |
0
Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according ...
Cancer
May 17, 2012 |
5 / 5 (4) |
0
|
Researchers find no disparities in imaging before breast cancer surgery
If racial and ethnic disparities in breast cancer exist, they are not due to differences in the use of imaging to assess the extent of tumors before surgery, according to new findings that will be presented by Fox Chase Cancer ...
Cancer
May 17, 2012 |
not rated yet |
0
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
May 16, 2012 |
5 / 5 (1) |
0
What price for a year of life? Cancer specialists offer contradictory advice
Cancer doctors prescribe medicines with little consideration of the cost, meaning they don't demand any more benefit (in months of survival) from a very expensive drug than from a less expensive one, a new research report ...
Cancer
Apr 20, 2012 |
not rated yet |
0
Michigan cancer programs follow care guidelines for common cancers, study finds
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.
Cancer
Apr 10, 2012 |
not rated yet |
0
Lung adenocarcinoma architecture predicts survival
(HealthDay) -- A new method of classifying invasive pulmonary adenocarcinomas, based on the predominant architecture developed by the International Association for the Study of Lung Cancer (IASLC)/American ...
Cancer
Mar 08, 2012 |
not rated yet |
0
Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting'
Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to ...
Cancer
Feb 02, 2012 |
5 / 5 (1) |
0
Study questions proton therapy for prostate cancer
A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does.
Cancer
Feb 01, 2012 |
5 / 5 (1) |
0
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Cancer
Jan 18, 2012 |
not rated yet |
0
American Society of Clinical Oncology issues annual report on progress against cancer
The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest ...
Cancer
Dec 05, 2011 |
not rated yet |
0
Almac devises test to detect likelihood of colon cancer recurring
The findings of Almac scientists' research have been published in the online version of the Journal of Clinical Oncology (JCO) ahead of the print edition of the journal. The JCO is the peer-reviewed publication o ...
Cancer
Nov 08, 2011 |
not rated yet |
0
